280 related articles for article (PubMed ID: 24401950)
1. Factor XIII deficiency management: a review of the literature.
Odame JE; Chan AK; Wu JK; Breakey VR
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):199-205. PubMed ID: 24401950
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Nugent DJ; Ashley C; García-Talavera J; Lo LC; Mehdi AS; Mangione A
Haemophilia; 2015 Jan; 21(1):95-101. PubMed ID: 25458735
[TBL] [Abstract][Full Text] [Related]
4. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.
Kerlin BA; Inbal A; Will A; Williams M; Garly ML; Jacobsen L; Kearney SL
J Thromb Haemost; 2017 Aug; 15(8):1601-1606. PubMed ID: 28581691
[TBL] [Abstract][Full Text] [Related]
5. Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
Nugent D
Thromb Res; 2012 Dec; 130 Suppl 2():S12-4. PubMed ID: 23439001
[TBL] [Abstract][Full Text] [Related]
6. A child with acquired factor XIII deficiency: case report and literature review.
Kessel R; Hu C; Shore-Lesserson L; Rand J; Manwani D
Haemophilia; 2013 Nov; 19(6):814-26. PubMed ID: 23607876
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients.
Williams M; Will A; Stenmo C; Rosholm A; Tehranchi R
Haemophilia; 2014 Jan; 20(1):99-105. PubMed ID: 23834599
[TBL] [Abstract][Full Text] [Related]
8. Factor XIII deficiency.
Hsieh L; Nugent D
Haemophilia; 2008 Nov; 14(6):1190-200. PubMed ID: 19141159
[TBL] [Abstract][Full Text] [Related]
9. Acquired Factor XIII Inhibitor in Hospitalized and Perioperative Patients: A Systematic Review of Case Reports and Case Series.
Tone KJ; James TE; Fergusson DA; Tinmouth A; Tay J; Avey MT; Kilty S; Lalu MM
Transfus Med Rev; 2016 Jul; 30(3):123-31. PubMed ID: 27167905
[TBL] [Abstract][Full Text] [Related]
10. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
Takahashi T; Hatao K; Suzukawa M; Oji T
Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
[TBL] [Abstract][Full Text] [Related]
11. The burden and management of FXIII deficiency.
de Jager T; Pericleous L; Kokot-Kierepa M; Naderi M; Karimi M
Haemophilia; 2014 Nov; 20(6):733-40. PubMed ID: 25039531
[TBL] [Abstract][Full Text] [Related]
12. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.
Levy JH; Greenberg C
Transfusion; 2013 May; 53(5):1120-31. PubMed ID: 22928875
[TBL] [Abstract][Full Text] [Related]
13. Blood coagulation factor XIII and factor XIII deficiency.
Dorgalaleh A; Rashidpanah J
Blood Rev; 2016 Nov; 30(6):461-475. PubMed ID: 27344554
[TBL] [Abstract][Full Text] [Related]
14. Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes.
Carcao M; Fukutake K; Inbal A; Kerlin B; Lassila R; Oldenburg J; Garly ML; Nugent D
Semin Thromb Hemost; 2017 Feb; 43(1):59-68. PubMed ID: 27556350
[TBL] [Abstract][Full Text] [Related]
15. Clinical Use of Factor XIII Concentrates.
Lassila R
Semin Thromb Hemost; 2016 Jun; 42(4):440-4. PubMed ID: 27071044
[TBL] [Abstract][Full Text] [Related]
16. Novel aspects of factor XIII deficiency.
Muszbek L; Bagoly Z; Cairo A; Peyvandi F
Curr Opin Hematol; 2011 Sep; 18(5):366-72. PubMed ID: 21738029
[TBL] [Abstract][Full Text] [Related]
17. Minimal factor XIII activity level to prevent major spontaneous bleeds.
Menegatti M; Palla R; Boscarino M; Bucciarelli P; Muszbek L; Katona E; Makris M; Peyvandi F;
J Thromb Haemost; 2017 Sep; 15(9):1728-1736. PubMed ID: 28688221
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor XIII A-subunit in a patient with factor XIII deficiency and recurrent pregnancy loss.
Al-Khabori M; Pathare A; Menegatti M; Peyvandi F
J Thromb Haemost; 2018 Jun; 16(6):1052-1054. PubMed ID: 29665207
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.
Naderi M; Dorgalaleh A; Alizadeh S; Tabibian S; Hosseini S; Shamsizadeh M; Bamedi T
Int J Hematol; 2014 Nov; 100(5):443-9. PubMed ID: 25230816
[TBL] [Abstract][Full Text] [Related]
20. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
